BioSpace News Archive

MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced the closing of its previously announced initial public offering of 3,333,334 shares of its common stock at a public offering price of $12.00 per share.

Iron sucrose injection is an iron sucrose solution that is dark brown in color; it typically comprises ~20 mg of iron per ml of the entire solution along with sucrose

Radiopharmaceutical therapeutics are defined as distinctive formulations of medicines that comprise radioisotopes and hence, these medicines are used as therapeutics to heal various diseases.

Rehabilitation is defined as various interventions that are designed to reduce different disabilities in individuals by providing optimized functioning with regard to the environment.

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced that its liquid biopsy focused subsidiary Inivata Limited has entered into a clinical collaboration with the Princess Margaret Cancer Center in Toronto, Canada, for the use of Inivata’s liquid biopsy assays, InVisionFirst®-Lung and RaDaR™ in two separate studies.

Versantis AG, a clinical-stage company developing novel therapies for rare liver diseases and rare pediatric diseases, announced the appointment of Prof Dr Katharina Staufer as Chief Medical Officer.

Pharnext SA is pleased to announce the strengthening of its senior management team with the appointments of Raj Thota, as Chief Manufacturing Officer and Head of CMC, Abhijit Pangu as the Head of Regulatory Affairs and the promotion of Xavier Paoli to Chief Operating Officer.

At a time when lung health is more important than ever, the American Lung Association announced that it has increased its research funding to award $12.6 million for more than 100 research grants.

Rocket Pharmaceuticals, Inc., a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces data presentations at the 28th Annual Congress of the European Society of Gene & Cell Therapy taking place virtually October 19-22, 2021.

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fourth patent by the US Patent and Trademark Office (USPTO).